Malignancy Risk Index in Pelvic Mass Differentiation

Abstract

Ovarian cancer is the seventh major cause of cancer-related death in women. Near 70% of epithelial ovarian cancers are diagnosed when the disease is advanced, when the 5-year survival rate is, approximately, 25%. The malignancy risk index (MRI) of ovarian tumors associates menopausal status, ultrasound characteristics and CA-125 serum levels, and has the goal of improving the preoperative distinction between benign and malignant ovarian tumors. So, we approuch this tool to regard how we should be find the best way to treat women with pelvic mass. In this paper we made a summarized review of MRI. In this article MRI and its componentes are reviewed. We understand that simplicity of Malignancy Risk Index calculation allows providing, with good accuracy, aid in differential preoperative diagnosis between benign and malignant tumors.